Data removes the barriers to understanding rare disease 

Rare disease research and treatment development is uniquely challenging given the limited understanding of rare and genetic diseases. De-identified, real-world data (RWD) features claims and electronic health record (EHR) data. Read how this robust, longitudinal patient view makes RWD an invaluable tool for stakeholders across the health system.


By completing this form you agree Informa may contact you directly about industry news, products, services and events that may be of interest to you subject to their privacy policy.   

All information that you supply is protected by our privacy policy. Terms of Use.